SCHEMBL19863520

SCHEMBL19863520

c1ccc(N(c2ccccc2)c2cccc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccc(-n7c8ccccc8c8ccccc87)cc6)c5c43)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ ATM Q13315 1/20 0.51
▸ MAPK8 P45983 2/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ PTPN1 P18031 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ PGR P06401 2/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10206022 0.96 L3MBTL1 (0.52) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL31707 0.90 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL26049279 0.90 KDM4E (0.52) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL10205988 0.90 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL19342643 0.90 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL15128468 0.90 KDM4E (0.46) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL5021397 0.89 KDM4E (0.59) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL10029889 0.89 KDM4E (0.59) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL13562925 0.88 L3MBTL1 (0.52) KDM4EL3MBTL1ATMMAPK8MAPK9
SCHEMBL10206021 0.88 KDM4E (0.57) KDM4EL3MBTL1ATMMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 — — US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 — — US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback